Movement Alert｜Hinge Health, Inc. Rises 5.09% in Regular Trading, Q2 Revenue Beats Expectations with Full-Year Guidance Sharply Raised

Market Focus08-05

On August 5, Hinge Health, Inc. rose 5.09% in regular trading, trading at $82.37/share, with turnover of $25.17 million. The rally was driven by a strong Q2 earnings report released after the prior session's close, featuring revenue that significantly exceeded expectations alongside a substantial upward revision to full-year guidance.

Hinge Health reported Q2 revenue of $212.8 million, up 53% year-over-year and well above the analyst consensus estimate of $201.5 million. Adjusted EPS came in at $0.59, meeting expectations. More importantly, the company raised its full-year revenue guidance to $856 million-$860 million, materially above the Street estimate of $822.2 million. Q3 revenue guidance of $223 million-$225 million also exceeded the $211.5 million consensus. Following the results, Morgan Stanley raised its price target to $117 from $108, maintaining an Overweight rating.

Hinge Health is an AI-driven digital musculoskeletal care platform that delivers end-to-end services from acute injury treatment to post-surgical rehabilitation through wearable devices and clinical teams.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1118473391?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 21:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1118473391","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hinge Health, Inc. Rises 5.09% in Regular Trading, Q2 Revenue Beats Expectations with Full-Year Guidance Sharply Raised","media":"Market Focus","content":"<p><p>On August 5, Hinge Health, Inc. rose 5.09% in regular trading, trading at $82.37/share, with turnover of $25.17 million. The rally was driven by a strong Q2 earnings report released after the prior session's close, featuring revenue that significantly exceeded expectations alongside a substantial upward revision to full-year guidance.</p><p>Hinge Health reported Q2 revenue of $212.8 million, up 53% year-over-year and well above the analyst consensus estimate of $201.5 million. Adjusted EPS came in at $0.59, meeting expectations. More importantly, the company raised its full-year revenue guidance to $856 million-$860 million, materially above the Street estimate of $822.2 million. Q3 revenue guidance of $223 million-$225 million also exceeded the $211.5 million consensus. Following the results, Morgan Stanley raised its price target to $117 from $108, maintaining an Overweight rating.</p><p>Hinge Health is an AI-driven digital musculoskeletal care platform that delivers end-to-end services from acute injury treatment to post-surgical rehabilitation through wearable devices and clinical teams.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hinge Health, Inc. Rises 5.09% in Regular Trading, Q2 Revenue Beats Expectations with Full-Year Guidance Sharply Raised</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hinge Health, Inc. Rises 5.09% in Regular Trading, Q2 Revenue Beats Expectations with Full-Year Guidance Sharply Raised\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-05 21:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 5, Hinge Health, Inc. rose 5.09% in regular trading, trading at $82.37/share, with turnover of $25.17 million. The rally was driven by a strong Q2 earnings report released after the prior session's close, featuring revenue that significantly exceeded expectations alongside a substantial upward revision to full-year guidance.</p><p>Hinge Health reported Q2 revenue of $212.8 million, up 53% year-over-year and well above the analyst consensus estimate of $201.5 million. Adjusted EPS came in at $0.59, meeting expectations. More importantly, the company raised its full-year revenue guidance to $856 million-$860 million, materially above the Street estimate of $822.2 million. Q3 revenue guidance of $223 million-$225 million also exceeded the $211.5 million consensus. Following the results, Morgan Stanley raised its price target to $117 from $108, maintaining an Overweight rating.</p><p>Hinge Health is an AI-driven digital musculoskeletal care platform that delivers end-to-end services from acute injury treatment to post-surgical rehabilitation through wearable devices and clinical teams.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HNGE","symbol_name":"Hinge Health, Inc.","start_time":0,"source_url":"","article_id":"1118473391","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1118473391","pubTimestamp":1785937594,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 5, Hinge Health, Inc. rose 5.09% in regular trading, trading at $82.37/share, with turnover of $25.17 million. The rally was driven by a strong Q2 earnings report released after the prior...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HNGE":"Hinge Health, Inc."},"translate_title":"走势提醒|Hinge Health, Inc. 常规交易上涨 5.09%，第二季度收入超出预期，全年指引大幅上调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HNGE":1},"content_text":"On August 5, Hinge Health, Inc. rose 5.09% in regular trading, trading at $82.37/share, with turnover of $25.17 million. The rally was driven by a strong Q2 earnings report released after the prior session's close, featuring revenue that significantly exceeded expectations alongside a substantial upward revision to full-year guidance.Hinge Health reported Q2 revenue of $212.8 million, up 53% year-over-year and well above the analyst consensus estimate of $201.5 million. Adjusted EPS came in at $0.59, meeting expectations. More importantly, the company raised its full-year revenue guidance to $856 million-$860 million, materially above the Street estimate of $822.2 million. Q3 revenue guidance of $223 million-$225 million also exceeded the $211.5 million consensus. Following the results, Morgan Stanley raised its price target to $117 from $108, maintaining an Overweight rating.Hinge Health is an AI-driven digital musculoskeletal care platform that delivers end-to-end services from acute injury treatment to post-surgical rehabilitation through wearable devices and clinical teams.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1118473391","isCrawlerRequest":true}